Statera Biopharma, Inc. (STAB) Financials

STAB Assets vs Liabilities

DateAssetsLiabilities
2022-09-30 21.2 million 22.7 million
2022-06-30 13.5 million 20.5 million
2022-03-31 13.5 million 15.9 million
2021-12-31 21.2 million 22.7 million

STAB Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2022-09-30 -8.2 million 1.1 million
2022-06-30 -168511 -1.1 million
2022-03-31 -3.8 million 452537
2021-12-31 -8.2 million 1.1 million

STAB Net Income

No data available :(

STAB Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2022-09-30 2.0 million - 1.0 million
2022-06-30 - - 1.2 million
2022-03-31 - - 1.2 million
2021-12-31 - - 1.1 million

STAB Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2022-09-30 35.1 million
2022-06-30 49.6 million
2022-03-31 50.0 million
2021-12-31 35.5 million

STAB Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2022-09-30 96913 5.6 million 4.6 million 53402
2022-06-30 - 973604 2.3 million -
2022-03-31 6454 3.2 million 3.8 million -
2021-12-31 6454 5.6 million 4.9 million -

STAB Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2022-09-30 1.3 million 372387
2022-06-30 - 200936
2022-03-31 - 353671
2021-12-31 - 372387

STAB

Price: $0

52 week price:
0.00
0.04

Earnings Per Share: -2.36 USD

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Volume: 370699

Market Capitalization: 42850

Links: